Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
- 30 November 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 17 (12), 1668-U189
- https://doi.org/10.1038/nm.2490
Abstract
Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood(1). Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT2B) on HSCs by serotonin, which activates expression of transforming growth factor beta 1 (TGF-beta 1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT2B enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT2B or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT2B attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT2B is clinically safe in humans and may be therapeutic in chronic liver disease.This publication has 31 references indexed in Scilit:
- Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adultsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- The c-Rel subunit of nuclear factor-κB regulates murine liver inflammation, wound-healing, and hepatocyte proliferationHepatology, 2009
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylationHepatology, 2006
- A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver FibrosisThe American Journal of Pathology, 2006
- Platelet-Derived Serotonin Mediates Liver RegenerationScience, 2006
- Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells – a potential mechanism for targeting liver anti-fibrotic therapeuticsJournal of Hepatology, 2005
- JunD Regulates Transcription of the Tissue Inhibitor of Metalloproteinases-1 and Interleukin-6 Genes in Activated Hepatic Stellate CellsPublished by Elsevier BV ,2001
- Cell proliferation and oncogene expression after bile duct ligation in the rat: Evidence of a specific growth effect on bile duct cells*1Hepatology, 1995
- Protooncogenes and growth factors associated with normal and abnormal liver growthDigestive Diseases and Sciences, 1991